As LFA-1 is important in helping the lymphocytes to stick to cells in the skin, efalizumab reduces the inflammation in the skin that causes psoriasis.
Kuna LFA- 1 on oluline lümfotsüütide kinnitumisel naharakkude külge, vähendab efalisumab psoriaasi põhjustavat põletikku nahas.